Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Hubbell Reports First Quarter 2025 Results
-
SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results
-
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025
-
Nexxen Announces April 2025 Share Repurchase Program Summary
-
Gain Therapeutics to Participate at The Citizens Life Sciences Conference
-
Miss America 2025 Abbie Stockard to Be Honored at Claire’s Place Foundation’s Clairity Ball 2025 – Casino Royale
-
Draganfly and Autonome Labs Announce Teaming Agreement to Deliver UAV-Based Demining Mesh Deployment Solution
-
Flow Capital Announces 2024 Annual Financial Results
-
HII Reports First Quarter 2025 Results
-
WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration
-
DTE Energy reports first quarter accomplishments, investments and earnings
-
Little Tikes® Becomes the Playground Super Hero with New Justice League™-Themed Toys
-
Altisource Announces First Quarter 2025 Financial Results
-
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
-
Crane NXT Completes Acquisition of De La Rue Authentication Solutions
-
Transaction in Own Shares
-
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
-
Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Eccogene Appoints Dr. Jai Patel as Chief Medical Officer
-
Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025
-
BioCryst Appoints Steve Frank to Board of Directors
-
Microbix Presenting at the 2025 Bloom Burton Conference
-
Sachem Capital Reports First Quarter 2025 Results
-
Enviri Corporation Reports First Quarter 2025 Results
-
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
-
Ligand to Participate in May Investor Conferences
-
Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
-
First Commonwealth Completes Acquisition of CenterGroup Financial, Inc.
-
Rehmann Announces Business Combination with Martinet Recchia
-
Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
-
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates
-
Lantronix to Report Fiscal 2025 Third Quarter Results on May 8, 2025
-
Atea Pharmaceuticals to Host Virtual HCV KOL Panel on May 14, 2025
-
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
-
Orezone Provides Update on RCF Block Trade to Australian Funds
-
FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain
-
Enthusiast Gaming’s U.GG Expands Analytics Platform to Support Rainbow Six Siege
-
Aduro Engages Siemens to Deliver Advanced Automation for Hydrochemolytic™ Pilot Plant
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025
-
Sol-Gel Announces Reverse Share Split
-
Resilinc Launches Agentic AI Platform for Supply Chain Risk and Compliance
-
Perspective Therapeutics to Participate in Upcoming May Investor Conferences
-
Old National Completes Closing of Bremer Bank Partnership
-
Inventus Signs MOU with McEwen Mining for Stock Mill Evaluation and Outlines Pardo Bulk Sampling Plan
-
Bitfarms Provides April 2025 Production and Operations Update
-
Axsome Therapeutics and Mental Health America (MHA) Join Voices to Highlight Mental Health Month
-
Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors
-
Kirby Corporation Announces 2025 First Quarter Results
-
FactSet Increases Dividend
-
Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET
